Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 0.776 Q2 | 202 | 335 | 1214 | 38296 | 5236 | 1130 | 3.90 | 114.32 | |
2 | Current Diabetes Reviews | journal | 0.696 Q2 | 68 | 93 | 280 | 7782 | 904 | 274 | 3.44 | 83.68 | |
3 | Current Molecular Pharmacology | journal | 0.694 Q3 | 49 | 71 | 166 | 7930 | 517 | 157 | 2.67 | 111.69 | |
4 | Current Cancer Drug Targets | journal | 0.687 Q3 | 103 | 69 | 228 | 5875 | 726 | 219 | 2.97 | 85.14 | |
5 | Current Drug Targets | journal | 0.621 Q2 | 119 | 110 | 419 | 12345 | 1457 | 403 | 3.15 | 112.23 | |
6 | Current Protein and Peptide Science | journal | 0.612 Q3 | 96 | 74 | 299 | 6244 | 966 | 277 | 2.58 | 84.38 | |
7 | Mini-Reviews in Medicinal Chemistry | journal | 0.570 Q3 | 107 | 162 | 450 | 17321 | 1925 | 442 | 3.98 | 106.92 | |
8 | Current Gene Therapy | journal | 0.564 Q3 | 80 | 36 | 122 | 3105 | 438 | 107 | 3.32 | 86.25 | |
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.558 Q3 | 52 | 35 | 97 | 3255 | 293 | 92 | 2.72 | 93.00 | |
10 | Current Genomics | journal | 0.548 Q3 | 77 | 36 | 176 | 2328 | 481 | 153 | 2.55 | 64.67 | |
11 | Current Bioinformatics | journal | 0.467 Q3 | 38 | 83 | 325 | 4428 | 1156 | 313 | 3.98 | 53.35 | |
12 | Open Biotechnology Journal | journal | 0.456 Q3 | 18 | 4 | 56 | 251 | 172 | 53 | 1.92 | 62.75 | |
13 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.428 Q3 | 108 | 286 | 635 | 21787 | 1751 | 622 | 2.76 | 76.18 | |
14 | Current Aging Science | journal | 0.405 Q4 | 42 | 28 | 61 | 1823 | 136 | 59 | 1.96 | 65.11 | |
15 | Current Organic Synthesis | journal | 0.377 Q3 | 55 | 58 | 208 | 3660 | 495 | 191 | 1.60 | 63.10 | |
16 | Open Medicinal Chemistry Journal | journal | 0.352 Q4 | 23 | 6 | 22 | 464 | 50 | 19 | 2.75 | 77.33 | |
17 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.298 Q4 | 39 | 20 | 62 | 1174 | 101 | 60 | 1.00 | 58.70 | |
18 | Infectious Disorders - Drug Targets | journal | 0.298 Q4 | 61 | 100 | 328 | 4928 | 482 | 311 | 1.40 | 49.28 | |
19 | Current Nanoscience | journal | 0.284 Q3 | 52 | 64 | 236 | 5132 | 387 | 228 | 1.65 | 80.19 | |
20 | Recent Patents on Biotechnology | journal | 0.276 Q3 | 42 | 23 | 79 | 2389 | 145 | 72 | 1.33 | 103.87 | |
21 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.270 Q4 | 45 | 29 | 106 | 1316 | 124 | 100 | 1.09 | 45.38 | |
22 | Current Computer-Aided Drug Design | journal | 0.258 Q4 | 32 | 42 | 195 | 1983 | 312 | 187 | 1.66 | 47.21 | |
23 | Drug Metabolism Letters | journal | 0.241 Q4 | 31 | 0 | 38 | 0 | 56 | 36 | 1.25 | 0.00 | |
24 | Letters in Drug Design and Discovery | journal | 0.192 Q4 | 37 | 89 | 355 | 4304 | 346 | 329 | 1.00 | 48.36 | |
25 | Letters in Organic Chemistry | journal | 0.186 Q4 | 33 | 141 | 363 | 5498 | 306 | 333 | 0.82 | 38.99 | |
26 | Open Biomarkers Journal | journal | 0.182 Q4 | 7 | 10 | 33 | 428 | 25 | 33 | 0.29 | 42.80 | |
27 | Current Pharmaceutical Analysis | journal | 0.178 Q4 | 27 | 88 | 340 | 4225 | 222 | 335 | 0.64 | 48.01 | |
28 | Current Chemical Biology | journal | 0.176 Q4 | 26 | 13 | 77 | 829 | 59 | 70 | 0.83 | 63.77 | |
29 | Current Proteomics | journal | 0.176 Q4 | 27 | 37 | 152 | 1775 | 111 | 145 | 0.91 | 47.97 | |
30 | Current Signal Transduction Therapy | journal | 0.176 Q4 | 22 | 17 | 85 | 673 | 90 | 75 | 1.05 | 39.59 | |
31 | Current Enzyme Inhibition | journal | 0.174 Q4 | 19 | 22 | 69 | 1028 | 44 | 61 | 0.69 | 46.73 | |
32 | Current Cancer Therapy Reviews | journal | 0.147 Q4 | 17 | 37 | 88 | 1901 | 43 | 79 | 0.52 | 51.38 | |
33 | Current Pharmacogenomics and Personalized Medicine | journal | 0.110 Q4 | 20 | 12 | 37 | 381 | 9 | 32 | 0.24 | 31.75 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®